Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-08-01 · accession 0001415889-24-020605 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-02 | 2024-08-01 | TVRD | Posner Christopher | Pres AND CEO, Dir | S - Sale | $0.35 | -4,149 | 172.4K | -2% | -$1,452 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 4,149 | $0.35 | 172,436 | D | — | — |